Literature DB >> 658232

Labeling of endotoxin lipopolysaccharide with technetium-99m pertechnetate.

R G Hamilton, R I Walker.   

Abstract

Bacterial endotoxin treated with technetium-99m can be visualized in living animals by gamma camera imaging.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 658232     DOI: 10.1007/BF01936972

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  8 in total

1.  Studies with radioactive endotoxin. II. Correlation of physiologic effects with distribution of radioactivity in rabbits injected with radioactive sodium chromate.

Authors:  A I BRAUDE; F J CAREY; M ZALESKY
Journal:  J Clin Invest       Date:  1955-06       Impact factor: 14.808

2.  Distribution and clearance of circulating endotoxin.

Authors:  W B HERRING; J C HERION; R I WALKER; J G PALMER
Journal:  J Clin Invest       Date:  1963-01       Impact factor: 14.808

3.  Localization of endotoxin in the walls of the peripheral vascular system during lethal endotoxemia.

Authors:  H S RUBENSTEIN; J FINE; A H COONS
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

4.  Tritiation of endotoxin.

Authors:  P A Tomasulo; S C March
Journal:  Biochim Biophys Acta       Date:  1975-08-19

5.  Double labelling of endotoxin with chromium and tritium: an interim report.

Authors:  L T Kocsár; L Vertok; L Varga
Journal:  Ann Immunol Hung       Date:  1973

6.  Fate of 51Cr-labeled lipopolysaccharide in tissue culture cells and livers of normal mice.

Authors:  J C Zlydaszyk; R J Moon
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

7.  On the absorption of bacterial endotoxin from the gastro-intestinal tract of the normal and shocked animal.

Authors:  H A RAVIN; D ROWLEY; C JENKINS; J FINE
Journal:  J Exp Med       Date:  1960-11-01       Impact factor: 14.307

8.  Characterization of a Cr51-labeled endotoxin and its identification in plasma and urine after parenteral administration.

Authors:  L CHEDID; R C SKARNES; M PARANT
Journal:  J Exp Med       Date:  1963-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.